Literature DB >> 24456503

Durable stabilization of three chordoma cases by bevacizumab and erlotinib.

T Asklund1, M Sandström, S Shahidi, K Riklund, R Henriksson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24456503     DOI： 10.3109/0284186X.2013.878472

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  13 in total

1.  [Novel molecular aspects of chordomas].

Authors:  S Scheil-Bertram
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.

Authors:  Susanne Scheipl; Michelle Barnard; Lucia Cottone; Mette Jorgensen; David H Drewry; William J Zuercher; Fabrice Turlais; Hongtao Ye; Ana P Leite; James A Smith; Andreas Leithner; Peter Möller; Silke Brüderlein; Naomi Guppy; Fernanda Amary; Roberto Tirabosco; Sandra J Strauss; Nischalan Pillay; Adrienne M Flanagan
Journal:  J Pathol       Date:  2016-05-31       Impact factor: 7.996

Review 3.  Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma.

Authors:  Vittoria Colia; Salvatore Provenzano; Nadia Hindi; Paolo G Casali; Silvia Stacchiotti
Journal:  Rep Pract Oncol Radiother       Date:  2016-01-13

Review 4.  Novel targeted therapies in chordoma: an update.

Authors:  Salvatore Di Maio; Stephen Yip; Gmaan A Al Zhrani; Fahad E Alotaibi; Abdulrahman Al Turki; Esther Kong; Robert C Rostomily
Journal:  Ther Clin Risk Manag       Date:  2015-05-26       Impact factor: 2.423

Review 5.  Chordoma: The Quest for Better Treatment Options.

Authors:  Christopher R Heery
Journal:  Oncol Ther       Date:  2016-03-03

6.  Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.

Authors:  Maurício Fernando Silva Almeida Ribeiro; Micelange Carvalho de Sousa; Samir Abdallah Hanna; Marcos Vinicius Calfat Maldaun; Ceci Obara Kurimori; Luiz Guilherme Cernaglia Aureliano de Lima; Romulo Loss Mattedi; Rodrigo Ramella Munhoz
Journal:  Case Rep Oncol Med       Date:  2018-04-10

7.  AZD8055 enhances in vivo efficacy of afatinib in chordomas.

Authors:  Tianna Zhao; I-Mei Siu; Tara Williamson; Haoyu Zhang; Chenchen Ji; Peter C Burger; Nick Connis; Jacob Ruzevick; Menghang Xia; Lucia Cottone; Adrienne M Flanagan; Christine L Hann; Gary L Gallia
Journal:  J Pathol       Date:  2021-07-28       Impact factor: 9.883

8.  Mutation Analysis of Nine Chordoma Specimens by Targeted Next-Generation Cancer Panel Sequencing.

Authors:  Carina Fischer; Susanne Scheipl; Agnes Zopf; Norbert Niklas; Alexander Deutsch; Mette Jorgensen; Birgit Lohberger; Elke Verena Froehlich; Andreas Leithner; Christian Gabriel; Bernadette Liegl-Atzwanger; Beate Rinner
Journal:  J Cancer       Date:  2015-08-20       Impact factor: 4.207

9.  Sustained response of a clivus chordoma to erlotinib after imatinib failure.

Authors:  Aline Houessinon; Mathieu Boone; Jean-Marc Constans; Patrick Toussaint; Bruno Chauffert
Journal:  Case Rep Oncol       Date:  2015-01-22

10.  Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series.

Authors:  Astrid Lipplaa; Sander Dijkstra; Hans Gelderblom
Journal:  Clin Sarcoma Res       Date:  2016-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.